Mercury Pharmaceuticals

Phone-based education significantly improves inhaler technique for COPD patients

Guiding people on how to correctly use inhaled medications via a phone-based program can help improve technique, according to a new study in the March 2026 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open access journal.

New bioelectronic interface enables long-term vagus nerve stimulation for inflammation

Electrical stimulation of vagus nerve via implantable stimulators can effectively suppress inflammatory responses, offering a novel strategy for treating autoimmune diseases.

Cryo-expansion microscopy reveals three-dimensional organization of killer T cells

Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells.

Eating creates temporary metabolic state that boosts T cell function

Diets and healthy eating habits hold promise for preventing and treating diseases, but far less is known about acute effects to the immune system shortly after a meal.

Nerve fibers within melanomas found to slow tumor growth

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators.

New map reveals B cell clusters linked to faster diabetic kidney disease

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells-specifically B cells-that are linked to faster disease progression.

New vaccine strategy neutralizes diverse HIV variants

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralising highly divergent HIV variants.

L.B. Bohle at Interpack 2026

L.B. Bohle exhibits state-of-the-art machinery at Interpack 2026, highlighting the PM 1000 blender and BFS fluidised-bed granulator for enhanced efficiency.

Diatron introduces advanced RUO indices on its Aquila, Aquarius 3, Abacus 5 analyzers

Diatron, a STRATEC brand specializing in the development, manufacturing, and marketing of hematology and clinical chemistry analyzers and related reagents for human and veterinary use, expands the capabilities of its Aquila, Aquarius 3, and Abacus 5 hematology analyzers with six advanced hematological indices.

Technique will turbocharge new medicines to combat antimicrobial resistance